Evidence map›Paper›PMID 21734132›Full record

ArticleThe American journal of tropical medicine and hygiene2011

Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh.

Genève M Allison, Kathleen A Rogers, Anoli Borad, Sabeena Ahmed, Mohammad Mahbubul Karim, Anne V Kane, Patricia L Hibberd, Elena N Naumova, Stephen B Calderwood, Edward T Ryan and 2 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. UnveilingFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Serum IgG Responses to gp15 and gp40 Protein-Derived Synthetic Peptides FromFrontiers in cellular and infection microbiology · 2021
    Article
  8. Article
  9. Case-Control Study of Cryptosporidium Transmission in Bangladeshi Households.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  10. Observational
  11. Review
  12. Asparagine-Linked Glycans ofMolecular & cellular proteomics : MCP · 2017
    Article
  13. Article
  14. Systemic and Mucosal Immune Responses toCurrent tropical medicine reports · 2015
    Article
  15. Review
  16. Article
  17. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article
  18. Sirtuins of parasitic protozoa: in search of function(s).Molecular and biochemical parasitology · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Genève M AllisonDivision of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111, USA. gallison@tuftsmedicalcenter.org
Kathleen A Rogers
Anoli Borad
Sabeena Ahmed
Mohammad Mahbubul Karim
Anne V Kane
Patricia L Hibberd
Elena N Naumova
Stephen B Calderwood
Edward T Ryan
Wasif A Khan
Honorine D Ward

Funding

Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
NEMCH CLINICAL RESEARCH ON AIDS TRAINING GRANTT32AI007438 · NIAID · TUFTS MEDICAL CENTER · PI WANKE, CHRISTINE A · 1992 to 2012
$2.5M
HIV PATHOGENESIS TRAINING PROGRAMT32AI007389 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 1990 to 2011
$2.3M
Midcareer Investigator Award in Patient-Oriented Research (K24)K24AT003683 · NCCIH · TUFTS MEDICAL CENTER · PI HIBBERD, PATRICIA L · 2006 to 2015
$1.9M
Molecular Basis of Crytosporidium-Host cell InteractionR01AI052786 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 2003 to 2007
$1.8M
NCCIH NIH HHS K24 AT003683NIAID NIH HHS R01 AI052786NIAID NIH HHS R01 AI52786NIAID NIH HHS T32 AI007389NIAID NIH HHS T32 AI007438NIAID NIH HHS T32 AI07389NIAID NIH HHS U01 AI058935NIAID NIH HHS UO1 AI45508
6 · The paper itself

Abstract

Although Cryptospridium hominis is the dominant Cryptosporidium species infecting humans, immune responses to cognate antigens in C. hominis-infected persons have not been reported. We investigated antibody responses to the immunodominant gp15 antigen from C. hominis and C. parvum, in C. hominis-infected Bangladeshi children less than five years of age with diarrhea (cases) and uninfected children with diarrhea (controls). We also investigated polymorphisms in the C. hominis gp15 sequence from cases. Serum IgG responses to gp15 from both species were significantly greater in cases than controls. In spite of polymorphisms in the gp15 sequence, there was a significant correlation between antibody levels to gp15 from both species, indicating cross-reactivity to conserved epitopes. Cases with acute diarrhea had a significantly greater serum IgA response to gp15 compared with those with persistent diarrhea, suggesting that this response may be associated with protection from prolonged disease. These findings support further investigation of gp15 as a vaccine candidate.

Indexed as

Polymorphism, GeneticAnimalsAntibodies, ProtozoanAntigens, ProtozoanBangladeshCase-Control StudiesChild, PreschoolCryptosporidiosisCryptosporidiumDiarrheaEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GInfantInfant, NewbornAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin G

Identifiers

PMID21734132
PMCPMC3122351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.